Alec Machiels - 15 Nov 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Issuer symbol
APLS
Transactions as of
15 Nov 2022
Net transactions value
-$56,675
Form type
4
Filing time
17 Nov 2022, 15:33:36 UTC
Previous filing
17 Oct 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $3,338 +1,250 +0.47% $2.67* 265,024 15 Nov 2022 Direct F1
transaction APLS Common Stock Sale $60,012 -1,250 -0.47% $48.01 263,774 15 Nov 2022 Direct F1
holding APLS Common Stock 250,000 15 Nov 2022 Indirect Owner (Bauhaus 1 LLC)
holding APLS Common Stock 11,950 15 Nov 2022 Indirect Owner (Owned by Spouse) F2
holding APLS Common Stock 150,000 15 Nov 2022 Indirect Owner (Spouse Trust)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -1,250 -1.1% $0.000000 114,779 15 Nov 2022 Common Stock 1,250 $2.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2021.
F2 These securities are owned by the reporting person's spouse.
F3 This option was granted on December 5, 2013 and is fully vested.